Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126624541 | 12662454 | 1 | I | 2009 | 20160519 | 20160817 | 20160817 | PER | US-ASTRAZENECA-2016SE55022 | ASTRAZENECA | 78.00 | YR | M | Y | 83.50000 | KG | 20160818 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126624541 | 12662454 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG 1 PUFF TWO TIMES A DAY | 21929 | ||||||||||
| 126624541 | 12662454 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 18265 | MG | 0 | 5 | MG | TABLET | QD | |||||
| 126624541 | 12662454 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 73060 | MG | 0 | 20 | MG | QD | ||||||
| 126624541 | 12662454 | 4 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 0 | 20 | MG | QD | ||||||||
| 126624541 | 12662454 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126624541 | 12662454 | 6 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Oral | 25.0MG AS REQUIRED | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126624541 | 12662454 | 1 | Chronic obstructive pulmonary disease |
| 126624541 | 12662454 | 2 | Blood pressure abnormal |
| 126624541 | 12662454 | 3 | Antacid therapy |
| 126624541 | 12662454 | 4 | Chronic obstructive pulmonary disease |
| 126624541 | 12662454 | 5 | Blood cholesterol abnormal |
| 126624541 | 12662454 | 6 | Vertigo |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126624541 | 12662454 | Dyspnoea | |
| 126624541 | 12662454 | Muscle spasms | |
| 126624541 | 12662454 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126624541 | 12662454 | 1 | 2013 | 0 | ||
| 126624541 | 12662454 | 2 | 2006 | 0 | ||
| 126624541 | 12662454 | 3 | 2006 | 0 | ||
| 126624541 | 12662454 | 4 | 2013 | 0 | ||
| 126624541 | 12662454 | 5 | 2015 | 0 | ||
| 126624541 | 12662454 | 6 | 2009 | 0 |